sb 202190 has been researched along with Infections, Orthomyxoviridae in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Börgeling, Y | 1 |
| Schmolke, M | 1 |
| Viemann, D | 1 |
| Nordhoff, C | 1 |
| Roth, J | 1 |
| Ludwig, S | 1 |
1 other study available for sb 202190 and Infections, Orthomyxoviridae
| Article | Year |
|---|---|
Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection.
Topics: Animals; Chlorocebus aethiops; Cytokines; Dogs; Enzyme Inhibitors; Female; Gene Expression Regulatio | 2014 |